Written Commentary
GOLD / SILVER
A preliminary report out of Israel suggesting that fully vaccinated individuals are protected against the Omicron variant lent support to equities and several commodity markets overnight, including the metals. Clearly, gold, silver, platinum, and palladium are tracking classic physical commodity supply and demand factors, as prices fell yesterday in the face of a flight to quality condition. However, the markets were also undermined by hawkish comments from the US Federal Reserve Chairman regarding the Fed’s need to pivot toward tightening before inflation becomes an issue.
PLATINUM
Platinum and palladium also saw some support overnight on the positive vaccine news from Israel and the generally supportive tone in equities and commodities, but this was after some aggressive liquidation on Tuesday. Both markets have been tracking classic commodity market fundamentals as opposed to garnering support from flight to quality.
COPPER
Copper held within a relatively tight inside-day range overnight, but they its posting gains coming into this morning’s action. The “risk on” mood across global markets has offset any pressure from the Caixin Chinese manufacturing PMI number, which was back below the key 50 level. Surprisingly, the market avoided the significant liquidation that was seen in many physical commodity markets yesterday.
Futures and options trading involve significant risk of loss and may not be suitable for everyone. Therefore, carefully consider whether such trading is suitable for you in light of your financial condition. The information and comments contained herein is provided by ADMIS and in no way should be construed to be information provided by ADM. The author of this report did not have a financial interest in any of the contracts discussed in this report at the time the report was prepared. The information provided is designed to assist in your analysis and evaluation of the futures and options markets. However, any decisions you may make to buy, sell or hold a futures or options position on such research are entirely your own and not in any way deemed to be endorsed by or attributed to ADMIS. Copyright ADM Investor Services, Inc.
